Warning! GuruFocus detected
2 Severe warning signs
with 2BO.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Serina Therapeutics Inc
NAICS : 541714
SIC : 2834
Description
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.7 | |||||
| Equity-to-Asset | 0.1 | |||||
| Debt-to-Equity | 0.42 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -106 | |||||
| 3-Year EPS without NRI Growth Rate | -148.5 | |||||
| 3-Year FCF Growth Rate | -95.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.31 | |||||
| 9-Day RSI | 59.92 | |||||
| 14-Day RSI | 56.82 | |||||
| 3-1 Month Momentum % | -9.65 | |||||
| 6-1 Month Momentum % | -22.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | |||||
| Quick Ratio | 2.4 | |||||
| Cash Ratio | 1.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.7 | |||||
| Shareholder Yield % | -14.6 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -62.24 | |||||
| ROIC % | -202.5 | |||||
| 3-Year ROIIC % | -1117.91 | |||||
| ROC (Joel Greenblatt) % | -384.31 | |||||
| ROCE % | -3721.67 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 79.26 | |||||
| Price-to-Tangible-Book | 75 | |||||
| EV-to-EBIT | -9.54 | |||||
| EV-to-EBITDA | -9.9 | |||||
| EV-to-FCF | -2.88 | |||||
| Price-to-GF-Value | 1.31 | |||||
| Earnings Yield (Greenblatt) % | -10.49 | |||||
| FCF Yield % | -31.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Serina Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -2.777 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 56.82 | ||
| 14-Day ATR (€) | 0.325866 | ||
| 20-Day SMA (€) | 4.051 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 1.86 - 11.3 | ||
| Shares Outstanding (Mil) | 9.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Serina Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Serina Therapeutics Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Serina Therapeutics Inc Frequently Asked Questions
What is Serina Therapeutics Inc(FRA:2BO)'s stock price today?
The current price of FRA:2BO is €4.50. The 52 week high of FRA:2BO is €11.30 and 52 week low is €1.86.
When is next earnings date of Serina Therapeutics Inc(FRA:2BO)?
The next earnings date of Serina Therapeutics Inc(FRA:2BO) is 2025-05-30 Est..
Does Serina Therapeutics Inc(FRA:2BO) pay dividends? If so, how much?
Serina Therapeutics Inc(FRA:2BO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers